Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 8, 2016 at 9:40 AM EDT

CRISPR Therapeutics Prepares for IPO

CRISPR Therapeutics expects to price more than 4 million shares in the range of $15 to $17 apiece for an…

Douglas A. McIntyre | Oct 7, 2016 at 9:05 AM EDT

Did EpiPen Maker Bilk Medicare for More Than $100 Million?

courtesy of Mylan Specialty L.P.From The Fiscal Times What happens when a major drug maker that does business with the…

Chris Lange | Oct 6, 2016 at 12:45 PM EDT

Idera Pharmaceuticals Sinks on Secondary Offering

Shares of Idera Pharmaceuticals sank on Thursday after the company announced that it intends to have a secondary offering.

Chris Lange | Oct 6, 2016 at 11:35 AM EDT

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its…

Chris Lange | Oct 6, 2016 at 10:20 AM EDT

Aurinia Pharma Skyrockets on Positive Data From Lupus Study

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been on a meteoric rise over the past month. In this time the stock…

Lee Jackson | Oct 6, 2016 at 9:50 AM EDT

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among…

Chris Lange | Oct 6, 2016 at 9:15 AM EDT

Why Scynexis Is Making a Run

Scynexis shares made a handy gain early on Thursday after the company announced the results from a couple of its…

Chris Lange | Oct 6, 2016 at 8:35 AM EDT

7 Key FDA Decisions and Clinical Trial Results Coming in Q4

24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in…

Chris Lange | Oct 5, 2016 at 12:35 PM EDT

Immunomedics Falls Sharply on Secondary Offering

Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.

Chris Lange | Oct 5, 2016 at 10:35 AM EDT

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries…

Chris Lange | Oct 4, 2016 at 3:02 PM EDT

Trinity Biotech Shares in Freefall After Withdrawing FDA Submission

Trinity Biotech PLC (NASDAQ: TRIB) is watching its shares get halved on Tuesday after the company announced that it would…

Paul Ausick | Oct 4, 2016 at 11:20 AM EDT

US Cities Where the Fewest Residents Lack Health Insurance

The Affordable Care Act (aka, Obamacare) is perhaps the signature piece of legacy legislation in President Obama's nearly completed two…

Chris Lange | Oct 4, 2016 at 10:35 AM EDT

Summit Therapeutics Skyrockets on Sarepta Deal

Shares of Summit Therapeutics more than doubled on Tuesday after it was announced that it would be entering into a…

Chris Lange | Oct 4, 2016 at 9:15 AM EDT

Key FDA Decisions and Trial Results Expected in October

24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.

Chris Lange | Oct 3, 2016 at 4:22 PM EDT

Jaguar Animal Health Stumbles on Secondary Offering

Jaguar Animal Health Inc. (NASDAQ: JAGX) filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding a secondary…

1 … 191 192 193 194 195 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

CRISPR Therapeutics Prepares for IPO

Did EpiPen Maker Bilk Medicare for More Than $100 Million?

Idera Pharmaceuticals Sinks on Secondary Offering

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Aurinia Pharma Skyrockets on Positive Data From Lupus Study

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Why Scynexis Is Making a Run

7 Key FDA Decisions and Clinical Trial Results Coming in Q4

Immunomedics Falls Sharply on Secondary Offering

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Trinity Biotech Shares in Freefall After Withdrawing FDA Submission

US Cities Where the Fewest Residents Lack Health Insurance

Summit Therapeutics Skyrockets on Sarepta Deal

Key FDA Decisions and Trial Results Expected in October

Jaguar Animal Health Stumbles on Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

CRISPR Therapeutics Prepares for IPO

Did EpiPen Maker Bilk Medicare for More Than $100 Million?

Idera Pharmaceuticals Sinks on Secondary Offering

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Aurinia Pharma Skyrockets on Positive Data From Lupus Study

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Why Scynexis Is Making a Run

7 Key FDA Decisions and Clinical Trial Results Coming in Q4

Immunomedics Falls Sharply on Secondary Offering

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Trinity Biotech Shares in Freefall After Withdrawing FDA Submission

US Cities Where the Fewest Residents Lack Health Insurance

Summit Therapeutics Skyrockets on Sarepta Deal

Key FDA Decisions and Trial Results Expected in October

Jaguar Animal Health Stumbles on Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check